Welcome Visitor, Sign Up for Free!

Mobius Recalls Lots of Contaminated Mitosol

En Español

mitosol injection package On January 10, 2013, Mobius Therapeutics, LLC voluntarily recalled lots of contaminated Mitosol 0.2 mg/vial. According to manufacturers, products in the lots may contain a strain of yeast and are unsuitable for treatment. Doctors prescribe the antimetabolite Mitosol to patients before undergoing surgery, specifically glaucoma filtration procedures. Physicians should not administer this product to any patients as it may be unsafe.

Recalled Mitosol products may be identified by:

  • expiration date: August 2013
  • lot numbers: M098260 and M086920
  • distribution dates: October 22, 2012- December 14, 2012

What to Do with Recalled Mitosol

Mobius has informed consumers of the recall via email, telephone and mail. Officials advise anyone who possesses recalled Mitosol products to call Mobius at 1-877-393-6486 for information on how to return the product and to schedule a replacement from unaffected lots. The U.S. Food and Drug Administration urges physicians and customers not to use any recalled products. Treatments performed with recalled Mitosol can result in:

  • severe eye damage
  • eye infections
  • vision loss or blindness

If you suffer from any serious side effects associated with the use of recalled Mitosol, contact the FDA MedWatch Adverse Event Reporting Program. FDA assistance may be found by:

For legal assistance through our expert attorneys, fill out the “Request Attorney Assistance” form located in the upper-right section of this page.